More about

University Of California San Francisco

News
July 07, 2020
1 min read
Save

Man achieves long-term HIV remission without bone marrow transplant

Man achieves long-term HIV remission without bone marrow transplant

Researchers reported the first case of long-term HIV remission without the need for a bone marrow transplant.

News
June 22, 2020
12 min read
Save

Lessons from HIV, Ebola can help mitigate COVID-19 stigma

Lessons from HIV, Ebola can help mitigate COVID-19 stigma

Gitanjali Pai, MD, AAHIVS, has devised a way to shield patients from the stigma of an HIV diagnosis and encourage them to continue to seek care.

News
June 22, 2020
1 min read
Save

Hooked on ID with Harry Lampiris, MD

Hooked on ID with Harry Lampiris, MD

As a second-year medical student, I was fascinated by microbiology and pharmacology. In my third year of medical school, it became clear to me that I wanted to work in a field that required the use of broad clinical skills (both inpatient and outpatient) and that focused on the complex relationship between patients and their environment. During residency, I always found the ID cases most compelling and interesting, and I was frequently awestruck by the clinical acumen of ID physicians. But, mostly, it was the concept of the “magic bullet,” first described by Paul Ehrlich, the Nobel Prize-winning father of antimicrobial chemotherapy, that spoke directly to me. The clinical impact of antimicrobial therapy “snatching patients from the jaws of death,” which I frequently observed as a resident physician, made it clear to me that I wanted to be intimately involved in this seemingly miraculous process.

News
June 17, 2020
2 min read
Save

Ophthalmic societies protest use of rubber bullets, tear gas on citizens

Thousands of Americans have taken to the streets to protest following the killing of George Floyd. The American Academy of Ophthalmology released a statement condemning the use of rubber bullets as a means of crowd dispersion.

News
June 05, 2020
3 min read
Save

Novel tremelimumab-durvalumab regimen safe, effective in advanced liver cancer

A single 300 mg priming dose of tremelimumab in combination with durvalumab appeared safe and active among patients with advanced hepatocellular carcinoma, according to study results presented during the ASCO20 Virtual Scientific Program.

News
April 22, 2020
11 min read
Save

‘We should have been prepared’: COVID-19 devastates vulnerable US

‘We should have been prepared’: COVID-19 devastates vulnerable US

A little more than 3 years before the United States announced its first confirmed case of what would come to be called COVID-19, Anthony S. Fauci, MD, told a gathering of students and global health experts at Georgetown University there was “no doubt” that the Trump administration would face a surprise infectious disease outbreak. Fauci’s experience as director of the National Institute of Allergy and Infectious Diseases for more than 30 years told him that it was inevitable. Since 2000 alone, there had been outbreaks of West Nile virus, severe acute respiratory syndrome (SARS) and Zika virus, the 2009 H1N1 influenza pandemic and the years-long West African Ebola epidemic.

News
April 22, 2020
5 min read
Save

Teaching ‘old drugs new tricks’: Experts rush to identify therapeutics for COVID-19

Teaching ‘old drugs new tricks’: Experts rush to identify therapeutics for COVID-19

The COVID-19 pandemic has left academic institutions, government bodies and the private sector scrambling to find drugs to combat the novel coronavirus.

News
April 18, 2020
1 min read
Save

American Cancer Society awards research, training grants

American Cancer Society awards research, training grants

The American Cancer Society approved $36.1 million in funding for 79 research and training grants.

News
April 05, 2020
1 min read
Save

Parker Institute for Cancer Immunotherapy awards grants to six early career researchers

Parker Institute for Cancer Immunotherapy awarded up to $2.75 million in grant funding to six early career researchers.

News
March 30, 2020
2 min read
Save

Range of motion after reverse shoulder arthroplasty improved with early or delayed rehabilitation

Range of motion after reverse shoulder arthroplasty improved with early or delayed rehabilitation

Published results showed significant and similar improvements in range of motion and other outcomes among patients who received either early or delayed rehabilitation after reverse total shoulder arthroplasty.

View more